Preventive Full-Body Scans Spark Renewed Debate Following Celebrity Brain Tumor Discovery

The practice of preventive full-body scans is drawing renewed attention following an announcement by a former participant on the reality television series “The Bachelor” that a brain tumor was identified through such a screening before any symptoms emerged. This revelation has intensified the ongoing discussion among medical professionals regarding the potential advantages and disadvantages of these comprehensive magnetic resonance imaging (MRI) screenings.

Interest in these scans has surged as public figures, including Kim Kardashian, Paris Hilton, and now Josh Seiter, have openly shared their experiences with preventive body scans. This trend has fueled consumer demand for the technology, even as the medical community continues to debate its efficacy for individuals without existing health concerns.

According to information from the Dana-Farber Cancer Institute, full-body scans utilize various imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), or positron emission tomography (PET). The primary objective of these screenings is to uncover early indicators of conditions like cancer, heart disease, and other physiological abnormalities.

The Argument for Proactive Screening

Dr. Daniel Durand, who serves as the chief medical officer at Prenuvo, a prominent U.S. provider of full-body scans, describes the procedure as a “virtual physical.” He explains that it allows a radiologist to examine the body's internal structures in a manner that a conventional annual physical examination cannot.

“Two licensed providers analyze this data, explain its relevance directly to you and offer you guidance on the next steps necessary to optimize your health,” he stated.

Typically, whole-body scans are not covered by health insurance. “My general understanding is that for screening purposes, the test is usually not covered, given the lack of documented clinical benefit versus harms,” one medical professional observed. However, some coverage might be available for individuals with high-risk genetic syndromes or other specific medical conditions.

Durand expressed optimism regarding future insurance coverage:

“Our hope is that over time, insurers will see the many benefits of our proactive approach to healthcare and will broaden coverage. We are actively engaged in several research studies that could provide a foundation for insurance reimbursement.”

The cost for full-body scans can reach up to $2,500, depending on the chosen provider and specific options. The leading providers of these scans are Prenuvo, based in California, and Ezra, located in New York City.

Durand emphasized the diagnostic capabilities of full-body scanning, particularly through MRI. He noted that MRI technology offers a comprehensive, non-invasive internal examination, capable of detecting a wide array of conditions, including various cancers and vascular issues like aneurysms, without exposing patients to potentially harmful radiation associated with CT scans.

He asserted that Prenuvo scans are designed to identify numerous diseases by detecting internal bodily changes visible via MRI. “So, in many cases, the earliest signs of diseases — like cancers, infections or aneurysms — will be seen,” he explained, adding, “By seeing them earlier, you can be treated earlier, hopefully before the disease has done little to no permanent damage.”

Medical Community Concerns and Risks

Despite the claims of early detection, many medical professionals express reservations. One doctor noted the significant upfront cost and the absence of a clear medical indication for widespread screening among low-risk, asymptomatic individuals. This leads to agreement with major medical organizations that routine whole-body MRI screening is not advisable for the general population.

The popularity of these scans is often attributed to celebrity endorsements, some of whom reportedly receive the scans for free, a practice one physician found troubling. He suggested that even receiving a free scan constitutes a business relationship requiring disclosure by the Federal Trade Commission (FTC). He also questioned the messaging:

“My understanding is that the companies themselves cannot claim their tests save lives, so they work with celebs who can make personal claims that are not subject to the same investigational scrutiny. This also sends a conflicting message to the consumer and creates confusion.”

Another physician highlighted that undergoing a full-body scan often inclines individuals to pursue every positive finding, regardless of its actual clinical significance. He also pointed out the substantial expense and the frequent oversensitivity of these scans. He cautioned that they might inadvertently replace more targeted and accurate diagnostic studies and screening tests that are better suited to a patient's specific symptoms, medical history, and genetic profile.

This physician also observed a contemporary shift towards more personalized healthcare models, enhanced by genetics and artificial intelligence. He predicted that this evolution would lead to more focused diagnostic investigations rather than an increase in general full-body scans.

The most significant hazards associated with these full-body scans, according to one doctor, revolve around the issues of false positives, overdiagnosis, and subsequent overtreatment. He also identified mental health risks, including anxiety during the procedure (especially for those with claustrophobia), stress resulting from incidental findings, and a general increase in health-related worries.

“Some proponents say it can ease health-related anxiety; however, I am pretty skeptical of that claim,” he stated. “Based on my clinical experience, even getting a clear scan would secure peace of mind only temporarily.”

Research from 2020 indicated that imaging abnormalities are anticipated in approximately 95% of individuals undergoing these screenings. “This means the majority of those scanned will have some sort of finding presented to them,” the doctor explained. “I can’t imagine how helpful that would be to someone already prone to health worries.”

During a 2025 podcast discussion, Andrew Lacy, CEO of Prenuvo, acknowledged that long-term data regarding these screening scans is not yet available. Reflecting on this, one medical expert commented:

“So, currently, we don't know if we are saving more people by catching disease early or harming more people with overdiagnosis, false positives and overtreatment. Barring emergencies, if I don't have clear data about the harms and benefits of an intervention, especially one that is meant to be used on healthy people, I cannot widely recommend it.”

Prenuvo did reference a recent study involving over 1,000 patients who were monitored for a year.

Official Health Guidance

The most recent guidance from the U.S. Food and Drug Administration (FDA) aligns with the concerns raised by medical professionals. On its website, the agency explicitly states: “At this time, the FDA knows of no scientific evidence demonstrating that whole-body scanning of individuals without symptoms provides more benefit than harm to people being screened.”

The FDA also issued a caution regarding the “relatively high radiation exposure” associated with CT scans. While acknowledging that the benefits of diagnostic and therapeutic scans generally outweigh this exposure risk, the agency deems the benefits of whole-body screening for asymptomatic individuals as “questionable.” The FDA advises: “Before having a CT screening procedure, carefully investigate and consider the potential risks and benefits and discuss them with your physician.”

Similarly, the American Academy of Family Physicians (AAFP) advises against the use of full-body scans for the early detection of tumors in patients who do not exhibit symptoms.